What is the usual cabergoline dose for hyperprolactinemia (high prolactin)?
Cabergoline dosing depends on why it’s being used, but for hyperprolactinemia (including prolactin-secreting pituitary tumors), treatment commonly starts low and is increased gradually based on prolactin levels and symptom response.
How is cabergoline typically started and titrated (what dosing schedule do clinicians use)?
A common approach is to begin at a low dose, then adjust upward every few weeks until prolactin normalizes and symptoms improve. Doses are individualized because people vary in how quickly prolactin falls and how well they tolerate side effects.
How often is cabergoline taken (daily vs weekly)?
Cabergoline is often prescribed as a once- or twice-weekly medication for long-term management in many conditions, but some regimens use more frequent dosing during the initial adjustment phase. Exact frequency should follow the prescribing clinician’s instructions.
What dose is used for Parkinson’s disease?
Cabergoline dosing for Parkinson’s disease is different from dosing for prolactin-related conditions and usually requires slow titration to reduce adverse effects. The daily target dose varies by patient and tolerability.
What side effects limit cabergoline dosing?
Common dose-limiting adverse effects can include nausea, dizziness/lightheadedness, headache, constipation, and fatigue. If side effects are significant, clinicians may reduce the dose or slow the titration.
What warnings matter for higher or long-term doses?
With long-term exposure—especially at higher doses—cabergoline has been associated with heart valve problems in some patients. That risk is one reason dosing is titrated carefully and why clinicians may monitor cardiac status depending on dose and treatment duration.
Can dosing differ between tablets and liquid formulations?
Dose adjustments are based on the active ingredient amount (typically measured in milligrams of cabergoline), but the exact mg-per-dose and whether the medication is an immediate-use versus other formulation can affect how clinicians prescribe it. Always match dosing to the specific product strength.
What should I check before taking cabergoline?
Because cabergoline dosing varies by indication and patient factors, confirm:
- the reason you’re taking it (hyperprolactinemia vs Parkinson’s vs other),
- the tablet strength you have,
- the exact titration plan your prescriber gave you.
If you tell me what condition you’re treating (and the tablet strength, e.g., 0.5 mg) plus your age and whether you’re already on therapy, I can help interpret the typical dosing pattern for that situation.